The 3<sup>rd</sup> International Conference on Drug Discovery & Therapy: Dubai, February 7 - 11, 2011

Anti-Cancer Discovery & Therapy (Track)



Identification of a novel biomarker for Herceptin resistance in HER2 postivie breast cancer cells

Incheol Shin
Incheol Shin Department of Life Science Hanyang University Seoul, South Korea

Abstract:

In an attempt to find novel protein biomarker(s) associated with Herceptin resistance in breast cancer, we have generated herceptin-resistant (HR) HER2-positive breast cancer cells from mouse xenograft model. The protein expression profiles of parental and HR cells were analyzed by differential proteomics using LC/MS-MS approaches. We have identified 688 differentially expressed proteins in parental and HR breast cancer cell lysates and 308 proteins in secretome. Some of the best candidate proteins were knocked-down in HR cells and their effect on cell proliferation, intracellular signaling, herceptin-resistance was investigated. The possible roles of the biomarker proteins in maintaining resistance to herceptin and their potential as a novel therapeutic candidates for herceptin-resistant breast cancer will be discussed.

Keywords: Breast cancer; Herceptin; Proteomics